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A b s t r a c t  
PLA microspheres loaded with the antibiotic Doxycycline are prepared using solvent evaporation 
technique (o/w) by varying the drug masses. They are evaluated for drug encapsulation, drug 
loading, particle size, morphology, FT-IR, stability and in vitro release. Microspheres loaded with 
Doxycycline show a maximum drug encapsulation of 38%. They exhibit homogeneous size 
distribution varying between 80 and 110 øm, with a spherical profile and porous surface. FT-IR study 
hasnÊt revealed any drug-polymer interaction. After 6 months of storage at different conditions, no 
appreciable difference is observed concerning the degradation of microspheres. In vitro release 
study of PLA microspheres loaded with Doxycycline reveals a rather fast release which requires only 
few hours to go to completion.  
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Introduction 
Drug delivery technology offers an intelligent approach in the 
medical field. It is based on encapsulating a drug into a carrier 
particle such as microspheres, nanospheres, and liposomes. 
Despite the several advancements in this technology, the oral route 
remains the most common route for the administration of 
therapeutic agents due to the low cost of therapy and ease of 
administration; thus leading to higher levels of patience compliance 
[1].Drug delivery systems possess many advantages including 
ease of application, site-specific action, prolonged delivery periods, 
and decreased body drug dosage with concurrent reduction in 
possible undesirable side effects [2, 3, 4]. In recent years, much 
research has been focused on the usage of biodegradable 
polymeric microspheres as novel drug delivery systems.Using 
biodegradable and biocompatible polymeric matrices in 
microspheres has many benefits for developing successful drug 
delivery systems. They provide sustained delivery of the drug, its 
localized delivery, and its stabilization [5, 6, 7]. Among the different 
classes of biodegradable polymers, the thermoplastic aliphatic 
esters as poly(lactic acid) ) (PLA) and its glycolic copolymer 
poly(lactic-co-glycolic acid) (PLGA)  are most commonly used as 
drug carriers due to their excellent biocompatibility, 
biodegradability, and mechanical strength [8]. They can degrade by 
non-enzymatic hydrolysis of the ester backbone in body fluids 
yielding metabolic compounds [9]. PLA was extensively studied in 
medical implants, sutures, and drug delivery systems [10]. A large 
number of drugs have been delivered using this polymer, such as 
the anti-cancer drugs Paclitaxel [11] and Aclacinomycin [12], the 
steroid hormone Progesterone [13], the opioid antagonist used to 
treat alcohol dependence Naltrexone [14], the non-steroidal anti-
inflammatory drugs Ibuprofen [15] and Indomethacin 
[16].Doxycycline is described as an antibiotic belonging to the 
family of Tetracyclines. It is used against many intracellular and 
extracellular pathogens [17, 18, 19]. Microspheres loaded with 
Doxycycline will be formulated using the o/w emulsion solvent 
evaporation technique, with the same coating polymer, poly(DL-
lactide) (PLA). Then, they will be characterized for drug loading 
and encapsulation efficiencies, particle size, morphology, stability, 
drug-polymer interaction, and in vitro drug release. 
Materials and methods 
PLA (MW 10, 000 g/mol), Doxycycline, Tween 80, and Phosphate 
Buffered Saline (0.2 M, pH 7.4) are all purchased from Sigma-
Aldrich, Chemie, Germany. Dichloromethane and Methanol used 
as solvents are of analytical grade. Doxycycline-loaded PLA 
microspheres are synthesized using the o/w solvent evaporation 
technique. This method consists of mixing an organic phase with 
an aqueous phase. X mg drug and 500 mg polymer are dissolved 
in a mixture of 14:6 ml. Dichloromethane/Methanol (DCM/MeOH) 
forming the organic phase. The continuous phase is made of 250 
ml water and 45 g Tween 80. The mixture is stirred continually for 6 
hours over a mechanical stirrer (MSP-1 Digital Overhead Stirrer, 
Jeiotech, Korea). The resulting solution is filtered in order to 
recuperate microspheres. They are washed with distilled water and 
MeOH, and then dried. 
Characterization 
Encapsulation Efficiency (%EE) and Drug Loading 
(%DL):Microspheres are dissolved in 7/3 ml DCM/MeOH and the 
drug content of each formulation is measured by UV/Vis 
Sectrophotometry (Microplate Spectrophotometer, Epoch Biotek, 
USA) at 275 nm. The percentage drug entrapment (%EE) and drug 
loading (%DL) are calculated as follows: 
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Particle size and morphology 
A Laser Diffraction Granulometer (LA950V2, Horiba Ltd., France) is 
used to determine the size of microspheres. A quantity of 
microspheres is suspended in water, with Tween 80 used as 
dispersant. The average particle size is measured in 
micrometers.The morphological characteristics of microspheres are 
examined by Scanning Electron Microscopy (SEM) (LYRA3 XMU, 
TESCAN, Czech Republic). Microspheres are fixed to a carbon 
conductive tape. A coating of 10 nm of Platinum is applied using a 
sputter coater. 
Fourier Transform Infrared (FT-IR) study 
FT-IR spectra of Doxy ăloaded PLA microspheres, PLA, and pure 
drug are recorded on FT-IR spectrometer (Frontier NIR, Perkin 
Elmer, USA) in order to investigate the possible chemical 
interactions between the drug and the blend matrix. 
Stability study 
Microspheres are stored at different experimental conditions for 
few months to check for any change in their physical appearance: 
In sealed tubes at different temperatures (4ĈC, 25ĈC, and 37ĈC). In 
Phosphate Buffered Saline (PBS) solution at 37ĈC.In acidic 
medium (PBS, pH 2) at 37ĈC Every 20 days, a certain quantity of 
the stored microspheres is evaluated by Optical Microscopy 
(LEICA DMLS2, Vashaw Scientific Inc., USA) 
In vitro drug release study 
The In vitro release study is carried out in PBS solution (0.2 M, pH 
7.4). 25 mg microspheres are introduced in small vial containing 10 
ml PBS, used as release medium, and maintained at 37ĈC. At 
different time intervals, 1 ml of the release medium is withdrawn 
and replaced with fresh solution. This is evaluated for its drug 
content at 347 nm.  
Results and Discussion 
O/w emulsion solvent evaporation, which is widely applied in 
pharmaceutical industry for controlled release of drugs, is used to 
prepare Doxy-loaded PLA microspheres. Different formulations 
were prepared by fixing the quantity of polymer, and changing the 
quantity of drug each time. They were indexed D1to D5. The %EE, 
%DL, and average particle size of the prepared microspheres are 
presented in Table 1. 
 
 







%EE % DL 
Average Particle Size 
(øm) 
D1 3 25 0.15 90
D2 8 38 0.16 88
D3 10 23 0.25 91
D4 20 6 0.20 87
D5 30 3 0.15 91
 
Moderate % EE values were observed, with a maximum of 38%, 
which corresponds to formulation D2 as shows Table 1. Obtained 
values for %EE and %DL of the different formulations are related to 
the properties of both the polymer and the drug. According to 
Mehta et. al., the solubility of polymers in organic solvents 
determines the precipitation rate during the microencapsulation 
process [20, 21]. PLA shows a high solubility in DCM; thus it has a 
tendency to remain in the organic layer. Its solidification rate will in 
turn decrease, leading to moderate drug encapsulation values. In 
addition, drug properties, such as the molecular weight and the 
solubility also affect the drug entrapment. Drugs having an average 
molecular weight easily diffuse out of the microspheres [20]. In the 
case of Doxy, its average molecular weight, that is 513 g/mol, 
enables its loss out of the polymeric matrix, by diffusion during or 
after preparation, which generates these observed % EE and % DL 
for the microspheres formulations. The solubility of the drug is also 
a key parameter in the encapsulation process [22]. Doxy is 
amphiphilic in character. It shows a good solubility in DCM; 
however, after mixing the organic phase with the continuous 
phase, it has a tendency to migrate to the aqueous solution during 
the preparation of microspheres, due to its high solubility in water. 
The prepared microspheres show a homogeneous particle size 
ranging between 80 and 110 øm (Table 1).  The drug-polymer 
interaction study is carried out by FT-IR spectroscopy. Spectra are 
recorded for PLA, Doxy, and drug-loaded microspheres. Table 2 
gives a summary of the characteristic bands in PLA and Doxy. 
Table 2.Characteristics Peaks of PLA and Doxycycline 
Absorption Peak ( cm-1) Type of bond 
PLA 
2994-2942 -CH3 and -CH stretching 
1748 -C=O  
1451-1382 -CH3 and -CH bending
1180 -C-O  
Doxycycline 
3327 -OH  
3277 -NH  
1610 -C=O  
1459 -CH2 bending 
 
The comparative spectra of Doxy, PLA and Doxy-loaded 
microspheres are shown in Figure 1. The drug can be easily 
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identified by the broad peak of -OH alcohol at 3300-3500 cm-1. 
Peaks observed around 2900-3000 cm-1 correspond to aliphatic -
CH and -CH3 of the polymer PLA. This result clearly indicates the 
stability of the drug during the microencapsulation process. Results 
also show small deviations of some polymer bands like from 1748 
to 1756 cm-1 and from 868 to 871 cm-1, probably due to the 
presence of Doxy. 
 
 
Figure1.FT-IR Spectra of (a) PLA, (b) Doxycycline-Loaded Microspheres, and (c) pure Doxycycline  
 
The morphology of the microspheres is examined by SEM. Figure 
2 shows the SEM microphotographs of Doxy-loaded micropheres. 
SEM reveales a spherical profile of the microspheres with a porous 
surface. Also microspheres forms aggregates. This is explained by 
Weihert et. Al. who reported that the surface of low-molecular 
weight PLA particles is more adhesive than that of particles from 
polymers with higher molecular weight, which causes an 




Figure 2. SEM Photographs of Microspheres taken at (a)1000x and 
(b)10000x magnifications 
The stability study performed at different temperatures (4ĈC, 25ĈC, 
and 37ĈC) for 6 months shows spherical microspheres with no 
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Figure 3.Microphotographs of Stability Study after 6 Months at 
Different Temperatures 
 
PLA is known to be hydrolytically unstable, although insoluble in 
water. It undergoes degradation by hydrolytic cleavage of ester 
bonds [22]. This breakdown becomes fast at higher temperature; 
but PLA can resist in PBS at 37ĈC for almost 2 months. Therefore, 
it is stable in biological media (Figure 4). Finally, the acidic media 
(pH 2) doesnÊt show an influence on PLA formulations (Figure 5). 
This indicates that microspheres can be taken orally and remain 
intact in the gastro-intestinal tract. 
 
Figure 4.Microphotographs of Stability Study in PBS at 37ĈC 
 
Figure 5. Microphotographs of Stability Study in pH 2 at 37ĈC 
 
The in vitro release profiles of Doxy formulations D1, D2, and D3, 
are shown in Figure 6. These formulations are chosen because 
they have the highest %EE. Results show that the drug release is 
fast and requires only few hours to go to completion. This can be 
explained by the high affinity of the drug towards PBS used as a 
release medium. The release rate is also higher for formulations 
having the lowest amount of drug (formulation D1). It becomes 
slower when higher amount is encapsulated in microspheres, thus 
the drug will take longer time to escape into the release medium. 
This result is particularly noticed in the case of fomulation D2 
characterized by the slowest release. At higher drug loading, the 
chances of particles to interact with each other are high. This 
causes the formation of particular aggregates, which extends into 
the polymer matrix and needs more time to dissolve. The initial 
burst release observed for D1 can be explained by the presence of 
surface associated drug. Besides, the absence of aggregates due 
to the small quantity of drug leads to fast dissolution into the 
release medium during the first few minutes, especially in the case 





Figure 6. In Vitro Release Profile of Doxy Microspheres 
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Doxycycline has been successfully encapsulated in PLA 
microspheres using the o/w emulsion solvent evaporation 
technique. Microspheres have a spherical and porous profile, with 
an average size of 80 to 110 øm. They show good encapsulation 
and drug loading values despite their hydrophilicity. FT-IR study 
reveals that the drug remains intact following the 
microencapsulation process. Microspheres are stable after storage 
at different conditions. The in vitro release is fast and needed few 
hours to reach the maximum. A controlled release followed by a 
burst release is observed for formulations with highest drug 
amounts. This study has showed that PLA could be used as a 
promising coating carrier for the encapsulation of pharmaceutical 
agents. 
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